Industry Payments to Physician Directors of National Cancer Institute–Designated Cancer Centers, 2015-2017-Reference-Cited by-同舟云学术

Industry Payments to Physician Directors of National Cancer Institute–Designated Cancer Centers, 2015-2017

Published:2019-11-01 Issue:11 Volume:179 Page:1595
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Carr David¹,Welch H. Gilbert²

Affiliation:

1. Department of Pathology, University of California, San Diego, La Jolla

2. Thetford, Vermont

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2740204/jamainternal_carr_2019_ld_190031.pdf

Reference6 articles.

1. Financial relationships with industry among national comprehensive cancer network guideline authors.;Mitchell;JAMA Oncol,2016

2. Industry funding among leadership in medical oncology and radiation oncology in 2015.;Yoo;Int J Radiat Oncol Biol Phys,2017

3. Industry payments to physicians and prescribing of brand-name drugs.;Steinbrook;JAMA Intern Med,2016

4. Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review.;Stamatakis;Eur J Clin Invest,2013

5. National Cancer Institute. Grants to NCI-designated cancer centers: NCI-designated cancer center totals, FY 2018. https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/cancer-centers. Posted December 20, 2018. Accessed April 3, 2019.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Promotions Between Ethics, Regulations, and Financial Interests;American Journal of Therapeutics;2024-05

2. Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?;Annals of Internal Medicine;2021-03

3. Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019;Cancer;2020-06-04

4. Disclose and Manage Conflicts of Interest at Cancer Centers—Reply;JAMA Internal Medicine;2020-01-01

5. Disclose and Manage Conflicts of Interest at Cancer Centers;JAMA Internal Medicine;2020-01-01